A detailed history of Bryce Point Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bryce Point Capital, LLC holds 31,144 shares of PFE stock, worth $743,407. This represents 0.61% of its overall portfolio holdings.

Number of Shares
31,144
Holding current value
$743,407
% of portfolio
0.61%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025

BUY
$25.01 - $27.13 $778,911 - $844,936
31,144 New
31,144 $805 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $134B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bryce Point Capital, LLC Portfolio

Follow Bryce Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryce Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bryce Point Capital, LLC with notifications on news.